The DAWN antivirals trial: process evaluation of a COVID-19 trial in general practice.

Tare, Dajana; Coenen, Samuel; De Sutter, An; Heytens, Stefan; Devroey, Dirk; Buret, Laetitia; Schoenmakers, Birgitte; Delvaux, Nicolas; Verbakel, Jan Y; Bogaerts, Kris; van den Bruel, Ann

Tare, Dajana; Coenen, Samuel; De Sutter, An; Heytens, Stefan; Devroey, Dirk; Buret, Laetitia; Schoenmakers, Birgitte; Delvaux, Nicolas; Verbakel, Jan Y; Bogaerts, Kris; van den Bruel, Ann.

Afiliación

Tare D; Academic Centre for General Practice, KU Leuven, Belgium.
Coenen S; Centre for General Practice, Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerpen, Belgium.
De Sutter A; Department of Public Health and Primary Care, Ghent University, KU Leuven, Belgium.
Heytens S; Department of Public Health and Primary Care, Ghent University, KU Leuven, Belgium.
Devroey D; Primary Care, Vrije Universiteit Brussel, Ixelles, Belgium.
Buret L; Department of General Medicine, University of Liège, Liège, Belgium.
Schoenmakers B; Academic Centre for General Practice, KU Leuven, Belgium.
Delvaux N; Academic Centre for General Practice, KU Leuven, Belgium.
Verbakel JY; Academic Centre for General Practice, KU Leuven, Belgium.
Bogaerts K; Department of Public Health and Primary Care, I-BioStat, KU Leuven, Leuven, Belgium.
van den Bruel A; Academic Centre for General Practice, KU Leuven, Belgium ann.vandenbruel@kuleuven.be.

BJGP Open ; 2024 Apr 17.

Article en En | MEDLINE | ID: mdl-37984980

Palabras clave

COVID-19; antiviral; primary healthcare; randomized controlled trial

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BJGP Open Año: 2024 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google